For self-renewal, embryonic stem cells (ESCs) require the expression of specific transcription factors accompanied by a particular chromosome organization to maintain a balance between pluripotency and the capacity for rapid differentiation. However, how transcriptional regulation is linked to chromosome organization in ESCs is not well understood. Here we show that the cohesin component RAD21 exhibits a functional role in maintaining ESC identity through association with the pluripotency transcriptional network. ChIP-seq analyses of RAD21 reveal an ESC specific cohesin binding pattern that is characterized by CTCF independent co-localization of cohesin with pluripotency related transcription factors Oct4, Nanog, Sox2, Esrrb and Klf4. Upon ESC differentiation, most of these binding sites disappear and instead new CTCF independent RAD21 binding sites emerge, which are enriched for binding sites of transcription factors implicated in early differentiation. Furthermore, knock-down of RAD21 causes expression changes that are similar to expression changes after Nanog depletion, demonstrating the functional relevance of the RAD21 -pluripotency transcriptional network association. Finally, we show that Nanog physically interacts with the cohesin or cohesin interacting proteins STAG1 and WAPL further substantiating this association. Based on these findings we propose that a dynamic placement of cohesin by pluripotency transcription factors contributes to a chromosome organization supporting the ESC expression program.
Introduction
The cohesin complex, consisting of four core subunits (SMC1a, SMC3, RAD21 and STAG (STAG1 or STAG2)), is important for a variety of biological processes including chromosome segregation, DNA-damage repair and chromosome morphology [1, 2, 3, 4, 5, 6] . A model of a ring-like structure suggests that cohesin can encircle DNA, thereby physically connecting different DNA strands for these diverse biological processes. Cohesin functions are supported by accessory proteins such as the cohesin loading factor NIPBL [7, 8] as well as the cohesin maintenance proteins WAPL [9, 10] and PDS5 [11, 12] .
Recent studies have extended the canonical functions to a role of cohesin in gene regulation [13, 14, 15, 16, 17, 18, 19, 20] . For instance, experiments have revealed that cohesin is loaded onto chromatin long before sister-chromatid cohesion is established [14] . Furthermore, cohesin is present in postmitotic cells and only a small amount is actually needed for mitosis [21, 22] . Association of cohesin with human developmental disorders occurring relatively late in development also proposed a functional role in gene expression regulation, because mutations that only affect sister-chromatid cohesion would predict to cause lethality early in development. However, disorders displaying mutations in the cohesin network termed cohesinopathies do not show severe defects in sister chromatid cohesion [14, 23, 24, 25] . Finally, the prominent co-localization with the chromatin boundary factor CTCF suggests a role of cohesin in chromatin mediated gene regulation [14, 24, 26, 27, 28, 29, 30, 31] . However, how cohesin contributes to the execution of specific gene expression programs is not well understood.
Interestingly, we and others recently identified cohesin subunits in RNAi ESC screens as factors that are required to maintain Oct4 expression [32, 33] . ESCs present an excellent cellular system to investigate a potential role of cohesin in gene regulation because the transcriptional repertoire that maintains ESC identity has been studied extensively and conditions for an exit from the self-renewal program are well defined.
Results

An organizational principle of RAD21 at CTCF binding sites
To gain insights into a potential role of cohesin in ESC biology, we performed a global DNA-binding survey of RAD21, a core component of the cohesin complex. We used a RAD21 BAC-GFP tagged ESC line and performed chromatin immunoprecipitation followed by massive parallel DNA sequencing (ChIP-seq) employing a high-affinity GFP-antibody. Applicability and specificity of the BAC tagging approach for generic assays has been demonstrated previously [34, 35] and has been specifically validated here for RAD21 (Fig. S1 ). For analysis of the ChIP-seq data set, we first subtracted the IgG ChIP-seq data from the Rad21 ChIP-seq data and employed the MACS algorithm (1.4.0beta version) to call binding peaks. With a cut-off p-value of 10e-5, we identified 15311 specific RAD21 binding sites (Table  S1 , Fig. S2 ) unmasking a characteristic binding pattern of RAD21 in ESCs.
Consistent with genome-wide binding studies for other cohesin subunits [24, 28] , inspection of the bound sequences did not reveal a RAD21 specific consensus sequence, indicating that the cohesin complex is not a sequence specific DNA binding complex. Instead, we identified the CTCF binding motif in 93% of all RAD21 binding sites. Cohesin has been shown to co-localize with the insulator protein CTCF, where it most likely contributes to chromosome organization via DNA loop formation between distant genomic regions [24, 30, 36] . To test whether this colocalization is indeed present in ESC, we also conducted ChIP-seq analysis with a validated CTCF BAC-GFP tagged cell line (Fig.  S1 ). Using the same parameters for peak detection, we identified 33788 CTCF binding sites in ESCs. We compared the RAD21 binding pattern to the CTCF binding sites in ESC and observed a remarkable overlap of the binding patterns of these two factors, with 73% of the RAD21 binding sites co-localizing with CTCF binding sites (Fig. 1A) .
Close inspection of the RAD21 and CTCF peaks revealed that RAD21 typically does not exactly overlap with the CTCF binding position. Instead, RAD21 peaks were slightly shifted in respect to the CTCF summits (Fig. 1B) . For a comprehensive analysis of this observation, we computationally determined the binding sites integrating all RAD21 peaks and calculated the distance to the closest CTCF binding motif in a strand specific manner. This analysis validated our initial observation and uncovered a directional placement of RAD21 59 of the CTCF motif (Fig. 1C) . Thus, our study reveals an hitherto unknown organizational principle of RAD21 binding close to CTCF sites in vivo.
CTCF-independent RAD21 binding sites preferentially co-localize with key pluripotency related transcription factors Despite the high overlap of RAD21 and CTCF binding, we also identified 4087 (26.7%) RAD21 binding sites that did not colocalize with CTCF in ESCs (Fig. 1A and Table S2 ). This result is consistent with previous studies in somatic cells, where non-CTCF bound sites for different cohesin components were reported [14, 28, 30] . Closer inspection of these binding sites revealed that 3420 (83.7%) of the non-CTCF bound binding sites contained the CTCF motif, indicating that they are either not bound by CTCF in ESCs, even though the binding motif is present or that these sites were not detected during ChIP-sequencing. To generate a list of unambiguous CTCF negative RAD21 binding sites we removed these sites, leaving 667 reassessed CTCF independent RAD21 binding sites, which we define as motif and CTCF-independent RAD21 binding sites (MCIB). To investigate whether other binding sites could be detected in this MCIB subset, we performed a motif search analysis in the vicinity (150bp) of MCIB RAD21 peak summits (Table S2) . Strikingly, this analysis showed an enrichment for DNA motifs that are known binding sites of key pluripotency transcription factors (Fig. 2B) . In particular, bona-fide binding motifs for Oct4 (encoded by Pou5f1), Nanog, Sox2, Klf4, and Esrrb were enriched at MCIB over all RAD21 binding sites. To investigate whether RAD21 does indeed colocalize with pluripotency transcription factors at these sites in vivo, we compared our data with published ChIP-seq data [37] of pluripotency transcription factors in ESCs. Remarkably, a significant overlap of MCIB RAD21 binding sites and the ESC transcription factors with a clear enrichment of ESC transcription factors at these particular MCIB sites over all RAD21 sites was observed (Fig. 2, Table S3 ). Moreover, many of the MCIB RAD21 sites co-localized with Multiple Pluripotency Transcription FactorBinding loci (MTL), from which around 40% were reported to be located in ESC intergenic regions [37] (Fig. 2A, Table S3 ). Interestingly, the MCIB RAD21 binding sites did not show a characteristic directional binding to the pluripotency transcription factor motifs as seen for CTCF co-bound sites.
RAD21 and other cohesin subunits are required to maintain ESC identity
The co-localization of RAD21 with pluripotency transcription factors prompted us to further investigate the functional role of RAD21 and other cohesion subunits in ESC maintenance. Because of its essential role during cell division, complete removal of cohesin causes cell death [38, 39, 40] . However, knock-down of cohesin complex components by RNAi has been used to investigate non-essential functions of the complex for instance in MCF-7 cells [28] . These experiments revealed that cells could divide and survive with reduced levels of cohesin proteins [22] . As in MCF-7 cells, transfection of ESCs with esiRNAs targeting RAD21, SMC1a or SMC3 resulted in significant depletion both at mRNA and protein level (Fig. 3A,B ) without causing pronounced cell death (data not shown). Importantly, ESC colonies lost their typical compact morphology 72 h post transfection with many flat and extended cells appearing at the periphery of colonies (Fig. S4) , suggesting loss of pluripotency. Alkaline phosphatase staining showed a strong reduction of AP-positive cells for knock-down of all three subunits, verifying the loss of pluripotency and subsequent differentiation upon cohesin depletion (Fig. 3 C,D, S5A ). The loss of AP expression upon RAD21 depletion was accompanied by a decrease in expression of pluripotency markers, including Oct4, Nanog and Myc (Fig. 3E) . Conversely, the expression of lineage markers characteristic for all three germ-layers (ectoderm: Fgf5, mesoderm: brachyury, endoderm: FoxA2) and trophectoderm (Cdx2) were strongly upregulated, signifying differentiation of the cells (Fig. 3F) .
To test whether the expression change of pluripotency and early developmental genes in RAD21 depleted cells is also valid for other cohesin subunits, we repeated the expression analysis with SMC1a and SMC3 depleted ESCs and detected similar expression changes of pluripotency and lineage markers (Fig. S5 B,C) . Although the magnitude of expression changes for some markers varied, possibly due to experimental variations, differences in knockdown efficiency or divergence in protein half-life, the overall concordance of the results were striking, indicating that the observed phenomena can be attributed to the cohesin complex rather than RAD21 itself. In summary, physiological expression of cohesin is required to maintain ESC identity.
Expression changes after RAD21 depletion resemble Nanog knock-down
To obtain a global view of expression changes, we transfected ESCs with RAD21 esiRNAs and measured expression changes after 48 hours using microarrays. Strong changes of the transcriptome were evident (Table S4) , supporting a role of RAD21 in ESC gene regulation. More importantly, many known stem cell maintenance genes, including Tbx3, Esrrb, Klf4, Fgf4, Nanog and Oct4 were downregulated (Fig. 4A, S6 ). In contrast, a large number of developmental genes from all three germ layers and the trophectoderm lineage were upregulated (Fig. 4A, S6) . Notably, many genes associated with known critical ESC maintenance signaling pathways, including the TGF-b, Wnt and Notch signaling pathways were also affected (data not shown). Gene Ontology enrichment analysis showed that genes associated with cell differentiation and development were strongly enriched (p. 5610 15 ) (Fig. 4B) , manifesting the exit of the pluripotency expression program and induction of differentiation programs upon RAD21 knock-down.
To place the observed expression changes into context of other factors, we compared the RAD21 expression profile to published data [41, 42] . Remarkably, the expression profile after RAD21 knock-down was similar to expression changes reported for the depletion of pluripotency transcription factors (Fig. 4C) . Thus, RAD21 knock-down mirrors expression changes observed after depletion of pluripotency transcriptional regulators. In particular, the depletion of RAD21 closely resembled the expression profile after Nanog knock-down with a Pearson correlation coefficient of 0.4 ( Fig. 4D,E) . Notably, this correlation coefficient matched or exceeded a comparison between Nanog and other pluripotency factors, indicating a particularly tight link between Nanog and RAD21 depletion (Fig. 4E ). This finding, together with the observed phenotypical consequences upon knock-down and the observed co-localization at MCIB RAD21 sites suggests that RAD21 is linked to the maintenance of ESCs through an association with pluripotency transcription factors. Co-localization of RAD21 with pluripotency related transcription factors at CTCF-independent sites is specific for ESCs
Functional relevance of RAD21 co-localizing with pluripotency maintaining transcription factors for ESC identity would suggest that these binding sites are ESC specific and that RAD21 would not be found there when cells exit the pluripotency program. To investigate this assumption, we differentiated LAP-tagged RAD21 ESCs into embryoid bodies (EBs) and performed ChIP-seq using the same parameters as employed previously for ESCs. With this analysis, we detected 11022 RAD21 binding sites in EBs. Interestingly, around half of the 15311 binding sites detected in ESCs, namely 7012 (45.8%), were also detected in EBs. This result suggests that many of the RAD21 binding sites are maintained upon differentiation (Fig. 5A ). In support for this observation, a lot of the unaltered RAD21 binding sites in ESCs are also conserved in B-and T-cells [24] (data not shown). In sharp contrast, the majority of the 667 MCIB RAD21 sites including the MTL colocalizing sites in ESCs had disappeared in EBs, indicating that the co-localization of RAD21 with pluripotency transcription factors is specific for ESCs ( Fig. 5A-D) . At the same time DNA binding motifs of transcription factors related to early development were now enriched at the MCIB RAD21 binding sites (Fig. 5B ), suggesting that these transcription factors now cooperate with cohesin to influence gene expression. As for the MCIB RAD21 binding sites in ESCs, we did not observe directional binding to transcription factor motifs ( Fig. S3 ) as seen for CTCF co-bound sites.
Nanog interacts with cohesin proteins STAG1 and WAPL
Because cohesin by itself does not seem to bind DNA sequence specifically, other mechanisms to place it at specific regions in the genome must exist. For RAD21 binding at CTCF sites, CTCF is suggested to localize cohesin via protein-protein interaction with STAG (SCC3) [30] . In order to gain insight into the mechanism of how cohesin is recruited to the ESC transcription factor binding sites, we performed a proteomic study on Nanog, the transcription factor with the highest enrichment score and the most similar expression pattern changes upon RAD21 depletion. Immunoprecipitation of LAP-tagged Nanog protein in Nanog-LAP-and control wildtype ESCs identified well known interaction partners of Nanog including Nr0b1, Zfp281, Sall4, Nac1, Gdf3, Sox2 and Rnf2 and thus validated functionality of the Nanog-LAP ESC line (Table S5) . Interestingly, we also detected the core cohesin protein STAG1 and the cohesin associated protein WAPL as interaction partners of Nanog (Fig. 6A) . To validate this result, we tested the interaction of STAG1 with Nanog by co-immunoprecipitation of GFP versus an IgG control in Nanog-LAP ESCs as well as in wildtype ESCs and confirmed the specific interaction in Nanog-LAP cells (Fig. 6B,C) . Collectively, these data indicate that Nanog may facilitate the placement of cohesin at its binding sites through an interaction with specific cohesin proteins and together with similar phenotypical consequences upon knockdown and co-localizing DNA-regions, suggests cooperativity between the non-specific DNA-sequence bound (chromatin organizer) cohesin and the specific DNA-sequence bound pluripotency transcription factors.
Comparative DNA binding analysis of cohesin sub-units Recently, the binding pattern of the cohesin subunits SMC1a and SMC3 were described in ESCs [43] . We re-analyzed these data sets (two replicates each, Fig. S7 ) and integrated our RAD21 data using the MACS algorithm (p,10
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) to calculate the number of common cohesin binding sites (Fig. 7A) , creating a list of high confidence common cohesin binding sites in ESCs (Table S7 ). We also integrated the different CTCF data sets to determine the number of common cohesin binding sites that are independent of CTCF. This analysis identified 16576 common cohesin binding sites, from which 2020 (12%) sites were independent of CTCF binding but still exhibit the CTCF motif sequence and 273 (1.7%) sites that are independent of CTCF binding and do not contain the CTCF motif sequence (MCIB). This result indicates that the number of cohesin binding sites that are independent of CTCF is lower then the number of sites where these proteins co-localize. This number becomes substantially smaller when also the sites that still contain the CTCF motif sequence are considered in this analysis.
Interestingly, the comparative analysis revealed binding sites of individual subunits that are not shared with other cohesin subunits (Fig. 7B ). This observation raises the possibility that, apart from a major concordance of core cohesin binding sites, individual cohesin subunits may bind to DNA in a unique manner. However, it is also possible that this observation is a result of the different ESCs and antibodies employed in the different studies or may also reflect experimental variability in ChIP-seq experiments.
Discussion
Cooperativity between mammalian transcription factors that bind sequence specific DNA elements and factors that mediate chromosome conformation have long been proposed, but molecular details on how they work together have been sparse. The recent implication of cohesin in regulating chromosome conformation [20, 27, 36, 44] together with its detection in ESC identity RNAi screens [32, 33] prompted us to investigate the role of RAD21 in ESCs in more detail. Our genome-wide RAD21 binding survey in ESCs and EBs revealed three modes of RAD21 binding, the conserved and the dynamic CTCF dependent and the CTCF independent binding mode.
The majority of sites that are co-occupied by CTCF and RAD21 appear to be conserved in ESCs and in different cell types, suggesting that they may provide a framework supporting a general chromosome architecture. Our observation that RAD21 exhibits a characteristic shifted directionality with respect to CTCF, which we did not observe for pluripotency transcription factor co-bound sites, might indicate a different functionality of RAD21 at the CTCF dependent compared to the independent sites or a different mode of physical interaction with the particular transcription factors. Physical interaction of cohesin with CTCF has recently been reported [30] , suggesting a direct role of CTCF in recruiting RAD21 59 of its binding site, although factors that mediate the placement cannot be excluded. In this context, a methylation dependent mechanism may account for recruiting cohesin because CTCF binds DNA in a methylation specific manner [16] . It will be interesting to further investigate how this placement is achieved and what relevance it has with respect to transcriptional insulation and chromosome architecture.
The comparative RAD21 binding analysis in ESCs versus EBs also uncovered changes in the CTCF dependent RAD21 binding sites, revealing the dynamic CTCF dependent RAD21 binding mode mentioned above. The fact that these sites change upon differentiation indicates that they may be important during development. Since the epigenetic chromatin state changes with differentiation [45] , the previously described DNA methylation dependency of CTCF binding [16] may account for the change of dynamic CTCF dependent binding of RAD21 in EBs. To further investigate this aspect, it will be interesting to compare the epigenetic changes with CTCF and cohesin binding sites during ESC differentiation in the future.
Probably the most intriguing finding was the identification of the motif and binding CTCF independent (MCIB) RAD21 binding sites that exhibited enrichment for pluripotency related transcription factors binding sites. The fact that these sites disappear in EBs and new binding sites emerge, which are enriched for early developmental transcription factors suggests that these sites are functionally relevant for the execution of developmental expression programs. The expression changes observed after RAD21 depletion mirroring knockdown of Nanog further support this notion.
Notably, the number of CTCF independent RAD21 binding sites in ESCs is considerably lower than reported for other cohesin subunits, namely SMC1a and SMC3 [43] . However, this is largely due to the different analysis methods employed and re-analysis of the data with our parameters also resulted in a much lower percentage of CTCF independent SMC1 and SMC3 binding sites including MCIB sites. Moreover, our comparative analysis revealed binding sites of individual subunits that are not shared with other cohesin subunits, suggesting that individual cohesin subunits are found at certain DNA sites. Whether this observation indeed reflects independent subunit binding or instead is a result of the different ESCs and antibodies employed or experimental variability in ChIP-seq experiments needs to be determined in the future. Nonetheless, independent of the analysis method employed, the cumulative data suggests that RAD21 together with the other cohesin proteins maintains ESC identity by connecting functionally relevant DNA elements. Thereby, it creates an ESC chromatin architecture that supports ESC specific gene expression programs.
With several ChIP-chip and ChIP-seq data sets published [14, 24, 28, 43] , a significant repertoire of cohesin and CTCF binding sites in various cell types is now available. The comparative analysis of CTCF and cohesin binding data published with this manuscript should provide a high confidence list for future studies. Eventually, an integrated analysis also from differentiated cells should allow a refinement of the cohesin binding patterns and may ultimately help to build a roadmap for chromosome architecture during development.
A remaining question is how the transcription factors interact with the cohesin proteins implicated in chromosome conformation. The study of Kagey and colleagues showed interaction of the cohesin loading factor NIPBL with the mediator complex [43] , of which the latter phenocopied cohesin in terms of ESC identity. In the study of Tutter and colleagues an interaction of the mediator component Med12 with Nanog was described [46] . Additionally, they found that Med12 and Nanog exhibited similar phenotypes, gene expression profiles and patterns of genome distribution. Another study revealed protein-protein interaction of Oct4 with SMC1a [47] . Our data suggest that Nanog may facilitate the placement of cohesin at its binding sites through an interaction with STAG1 and/or WAPL. Considering the fact that cohesin colocalizes at multiple transcription factor loci, the direct interaction of Oct4 with SMC1a and Nanog with STAG1 and WAPL may support the pluripotency transcription factor mediated placement of cohesin at CTCF-independent binding sites.
Collectively, these data suggest a complex interplay of the different co-localizing protein complexes and strongly indicate that these factors act in concert to maintain embryonic stem cell identity. However, a possible hierarchy of events and functions for the cooperativity of RAD21 and other cohesin subunits with pluripotency transcription factors at these sites needs future investigations. A detailed dissection of interactions between cohesin proteins and pluripotency transcription factors will certainly enhance our understanding of transcriptional regulation in light of higher order chromosome architecture.
Methods
Cell culture
Feeder-free mouse R1/E ESC were maintained on gelatincoated dishes in DMEM (GLUTAMAX high-glucose, Gibco) media supplemented with 15% FBS (Gibco), 0.055 mM bmercaptoethanol (Gibco), 16 MEM non-essential amino acids (Invitrogen), 5000 u/ml penicillin-streptomycin (Invitrogen) and 16 ng LIF (in house production as previously described [32] )/ 250 ml medium.
BAC transgenomics
BACs harbouring the genes of interest were obtained from the BACPAC Resource Center (http://bacpac.chori.org; BAC-IDs: RP23-375K15 (RAD21), RP23-236B2 (CTCF) and RP24-230P19 (Nanog)). A LAP cassette [48] was inserted as a C-terminal fusion using recombineering technology [49] (Gene Bridges). Isolated BAC DNA was transfected and selected for stable integration as described [34] . Resistant clones were additionally sorted for GFPpositive cells by FACS. Correct protein size and localization was verified by Western blot and immunofluorescent staining as described previously [34] . 
Embryoid body differentiation
RNA interference
Mouse esiRNAs were produced as described previously [50] . Primer sequences are listed in Table S6 . EsiRNA transfection was performed for 48 h using Lipofectamine2000 (Invitrogen) according to the manufacture's instructions with 800 ng esiRNA, 2 ul transfection reagent and 80000 cells per well in 12-well plates.
Western Blot
Cells were harvested and 10-20 ug of total protein extracts were separated on NuPage 4-12% Bis-tris gels (Invitrogen) and blotted on nitrocellulose membranes (Millipore). Membranes were probed with antibodies against GFP (MPI-CBG antibody and protein production facility, 1:10000), SMC1 and SMC3 (Bethyl Laboratories, Inc., Cat.No. A300-055A and A300-060A, 1:5000) and RAD21 (Santa Cruz, sc-56208, 1:500). GAPDH (Novus Biologicals NB300-221, 1:50.000) was used as a loading control.
Alkaline Phosphatase staining
Three days post RNAi, cells were fixed with 4% paraformaldehyde (Sigma), rinsed in PBS and stained using Alkaline Phosphatase Red Microwell substrate (Sigma). Images were acquired with a Canon Power Shot G11 digital camera on the Olympus CKX41 microscope.
Based on the staining intensity, percentages of differentiated, half-differentiated and undifferentiated cells were determined by counting.
RNA isolation, cDNA synthesis and quantitative real-time PCR
For isolation of total RNA the RNeasy Mini Kit (Qiagen) was used according to the manufacture's protocol including a DNaseI digest. Reverse transcription of 0.5-1 ug RNA was performed using Oligo-dT [12] [13] [14] [15] [16] [17] [18] and Superscript III kit (Invitrogen). Quantitative real-time PCR analysis was carried out using SYBR green master mix (Abgene) and the MxP3000 detection system (Stratagene). Samples were run in triplicate and transcript levels were calculated according to the DDct method with normalization to CyclophilinB. Primer sequences are listed in Table S6 .
Immunoprecipitation and mass spectrometry
Immunoprecipitation reactions were carried out with nuclear extracts from Nanog-LAP ESC as well as wildtype ESC and subjected to shotgun mass spectrometry as previously described [51] . For co-immunoprecipitation analysis, nuclear extracts of Nanog-LAP ESC or wildtype ESC were prepared using nuclear extraction reagents (Pierce) and precipitated using a GFP-antibody (MPI-CBG antibody facility). For the Nanog-LAP ESC line, an additional IgG isotype control antibody (Dianova) was used. Western blot detection was performed using GFP (11814460001, Roche) and STAG1 (sc-54515, SantaCruz) antibodies.
Microarray analysis
Cells were harvested two days post RNAi and 250 ug of isolated total RNA was labeled with the One-Cycle Target Labeling and Control Reagent Package (Affimetrix) as described in the manufacture's instructions. Probes from 4 biological replicates of RAD21 and Luc RNAi were hybridized on Mouse Genome 430.2.0 arrays (Affimetrix). Image data were analyzed with the GeneChip Operation Software applying Affimetrix default settings. Expression changes were determined by a parametric analysis of variance (ANOVA) after RMA normalization with respect to the probe GC content using Partek Genomics Suite 6.4 (6.09.0129) (Table S4) .
Gene Ontology analysis was performed using GenCoDis 2.0 [52, 53] .
For calculation of Pearson's correlation factor, published microarray data were used [41, 42] .
ChIP and ChIP-sequencing RAD21-LAP ESC were crosslinked with 1% formaldehyde for 10 min at room temperature and crosslinking was quenched with 125 mM glycine. Sonicated chromatin with an average size of 500 bp was immunoprecipitated over night using a GFP-antibody (MPI-CBG antibody facility) and control IgG-antibody (Dianova) and immobilized on G-sepharose (GE Healthcare). Specificity of the GFP-antibody has been validated before (Poser et al. 2008 , Fig. S1 ). Eluates were reverse crosslinked followed by RNA and protein digestion. Quantitative real-time PCR analysis was performed with 3 biological replicates of purified DNA. Relative occupancy values were calculated as fold enrichment over controlIgG (or as percent of input recovery occupancy) and normalized to RPL19. Primer sequences are listed in Table S6 .
For sequencing, 20 ng of the immunoprecipitated DNA was used to generate the ChIP-seq library according to the manufacture's protocol (Illumina) and sequenced with the Genome Analyzer II (Illumina).
Peak calling
Peak calling was performed using MACS 1.4beta [54] with the following settings for the RAD21 data: mfold = 8, bw = 150 and a p-value threshold of 10
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, and with the following settings for the previously generated data [37] : mfold = 8, bw = 150 and a p-value threshold of 10 25 . Prior peak detection, ChIP-seq fragment coordinates from CTCF, Pou5f1, Nanog, Sox2, Klf4 and Esrrb ChIP-seq data [37] were converted into Mouse NCBI genome build 37 (mm9) using the UCSC liftOver tool [55] .
Gene loci identification and genomic distribution PINKTHING (http://pinkthing.cmbi.ru.nl) software was used for assigning sites to the nearest gene and to determine genomic distribution of identified binding sites. Peak locations were visualized using the University of California Santa Cruz (UCSC) genome browser.
All sequence analyses were conducted based on the Mus musculus NCBI m37 genome assembly (mm9; July 2007) accessed from Ensembl.
Motif analysis
Sequences from a range of 150 bp around peak summits were extracted with BEDTools package (http://code.google.com/p/ bedtools) and used as a basis for further search of occurrences of known transcription factor binding motifs from the JASPAR database [56] . The search was performed using FIMO tool from the MEME suite [57] . Motif occurrences with a p-value not exceeding 10 25 were considered significant. Gaussian mixture modeling of distances between binding sites and motifs was performed with R package mclust (Fraley & Raftery, 2002) .
RAD21 binding peaks that were not overlapping with any of the CTCF peaks, were named CTCF independent RAD21 binding sites (CIB). Peaks that were not bound by CTCF and did not contain the CTCF binding motif in the 150 bp vicinity of the peak summits were considered motif and CTCF binding independent binding sites (MCIB). The binding site and the motif enrichment p-values were determined with Fisher's exact test. Enrichments were calculated using all RAD21 binding sites as background.
Accession number
MIAME compliant microarray and sequencing data from this study have been deposited in the MIAME compliant database GEO with the accession number GSE24030. 
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